Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem use in sepsis at Hospital Universitari de Bellvitge
2011-005902-30Phase 4Active
- Sponsor
- Bellvitge University Hospital
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of meropenem in sepsis and bacterial disease, sponsored by Bellvitge University Hospital. Started Jan 2012; status: active.
02
Drugs
meropenem
03
Conditions
sepsisbacterial disease
Beyond the preview
Go deeper on 2011-005902-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005902-30.